newsfilter
← Latest News
Business Wire·

Tempus Announces Multi-Year Collaboration with Moderna and Merck

Collaboration to Support Potential Commercialization of Intismeran Autogene Tempus (NASDAQ:TEM) today announced an expanded, multi-year collaboration to support the potential commercialization of intismeran autogene